MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$12,462K
Net Income
-$638K
Net Profit Margin
-5.12%
EPS
-$0.02
Unit: Thousand (K) dollars
Revenue Breakdown
Amount of gross revenue recogniz...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
Total revenues
12,462
Cost of product sales
660
Research and development
29
Selling and marketing
5,210
General and administrative
6,752
Total operating expenses
12,651
(loss)/income from operations
-189
Unrealized foreign exchange gain/(loss)
-3
Amortization expense
12
Interest income
152
Interest expense
586
Total other expense
-449
Net (loss)/income
-638
Basic EPS
-0.02
Diluted EPS
-0.02
Basic Average Shares
27,889,000
Diluted Average Shares
27,889,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss)/income
-$638K
Amount of gross revenue
recognized from goods sold,...
$13,668K
Total other expense
-$449K
(loss)/income from operations
-$189K
Interest income
$152K
Total revenues
$12,462K
Amount of cash inflow
from customers for...
-$1,206K
Interest expense
$586K
Total operating
expenses
$12,651K
Amortization expense
$12K
Unrealized foreign
exchange gain/(loss)
-$3K
General and
administrative
$6,752K
Selling and marketing
$5,210K
Cost of product sales
$660K
Research and development
$29K
Buy us a coffee
FENNEC PHARMACEUTICALS INC. (FENCF)
FENNEC PHARMACEUTICALS INC. (FENCF)